Fig 1.
HbA1c, glycated hemoglobin; T2D, type 2 diabetes.
Table 1.
Study population characteristics at index date (when basal insulin was initiated).
Fig 2.
CoDiC Computerized Diabetes Care database; HbA1c, glycated hemoglobin.
Fig 3.
a. Mean HbA1c over time relative to first HbA1c ≥7.0% (≥53.0 mmol/mol) on or after the 180-day basal insulin titration period, stratified by intensification status; b. Mean HbA1c over time after treatment intensification; c. Time to treatment intensification after HbA1c ≥7.0% (≥53.0 mmol/mol). Fig 3A and 3B: n, number of patients contributing to each data point. HbA1c, glycated hemoglobin.
Fig 4.
Daily insulin dose after intensification by insulin regimen a. basal–bolus insulin b. premix insulin. Data are observed mean based on the number of patients on a particular regimen at a given time point. n, number of patients with data for that time point. Patients who changed from basal–bolus insulin to premixed insulin, or vice versa, during the study contribute data to both panels of the figure.